Effect of various forms of the C1 esterase inhibitor (C1-INH) and DAF on complement mediated xenogeneic cell lysis

被引:21
作者
Fukuta, D
Miyagawa, S
Yamada, M
Matsunami, K
Kurihara, T
Shirasu, A
Hattori, H
Shirakura, R
机构
[1] Osaka Univ, Grad Sch Med, Div Organ Transplantat, Dept Regenerat Med, Suita, Osaka 5650871, Japan
[2] Anim Engn Res Inst, Ibaraki, Japan
[3] Nipro Corp, Res & Dev Lab, Osaka, Japan
关键词
C1-INH; complement; xenograft;
D O I
10.1034/j.1399-3089.2003.01120.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The purpose of the present study was to assess the effect of various forms of the surface-bound form of the C1 esterase inhibitor (C1-INH-PI) and decay accelerating factor (DAF) on xenogenic cells. cDNAs of various deletion mutants of the C1-INH-PI, such as delta-1-99 amino acid (AA), delta-108-183AA loop, delta-whole loop, delta-exon5, delta-exon6 + 7, and delta-exon5 + 6 + 7, and that of DAF, the delta-short consensus repeat (SCR) 1-DAF were established. While all deletion mutants of C1-INH-PI except the delta-1-99AA were expressed in the cytoplasm but not on the cell surface, the delta-1-99AA was clearly expressed on the xenogeneic cell surface. Amelioration of complement-mediated xenogeneic cell lysis by delta-1-99AA was next tested, and compared with delta-SCR1 DAF. Both molecules blocked human complement-mediated cell lysis by approximately 57 to 90 and 93 to 98%, respectively, in Chinese hamster ovarian tumor (CHO) cells and pig endothelial cells (PECs). The CHO cell transfectants were incubated with 20% normal human serum, and the amounts of C4 and C3 deposition on the cell surface were analysed by flow cytometry. The DAF transfectant showed a large amount of C4-deposition and much less C3-deposition than the controls (approximately 85% suppression), whereas the delta-1-99AA showed approximately a 40% suppression in both C4- and C3-deposition. Consequently, both the delta-1-99AA C1-INH-PI and delta-SCR1 DAF molecules are quite effective in down-regulating the xenogeneic cell lysis, but accomplished this in different manners.
引用
收藏
页码:132 / 141
页数:10
相关论文
共 50 条
[31]   The role of C1 inhibitor and complement as acute phase reactants: are we missing the diagnosis of hereditary angioedema? [J].
Stepaniuk, Peter ;
Bosonea, Ana-Maria ;
Pourshahnazari, Persia ;
Roos, Adrienne ;
Kanani, Amin .
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2021, 17 (01)
[32]   Recombinant expression of the autocatalytic complement protease MASP-1 is crucially dependent on co-expression with its inhibitor, C1 inhibitor [J].
Degn, Soren E. ;
Thiel, Steffen ;
Jensenius, Jens C. .
PROTEIN EXPRESSION AND PURIFICATION, 2013, 88 (02) :173-182
[33]   PeptiDe inhibitor of complement C1, a novel suppressor of classical pathway activation: mechanistic studies and clinical potential [J].
Sharp, Julia A. ;
Whitley, Pamela H. ;
Cunnion, Kenji M. ;
Krishna, Neel K. .
FRONTIERS IN IMMUNOLOGY, 2014, 5
[34]   Trypanosoma carassii calreticulin binds host complement component C1q and inhibits classical complement pathway-mediated lysis [J].
Oladiran, Ayoola ;
Belosevic, Miodrag .
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2010, 34 (04) :396-405
[35]   A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations [J].
Bowen, B ;
Hawk, JJ ;
Sibunka, S ;
Hovick, S ;
Weiler, JM .
CLINICAL IMMUNOLOGY, 2001, 98 (02) :157-163
[36]   Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7 [J].
Lathem, WW ;
Bergsbaken, T ;
Welch, RA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (08) :1077-1087
[37]   Nebulized C1-Esterase Inhibitor does not Reduce Pulmonary Complement Activation in Rats with Severe Streptococcus Pneumoniae Pneumonia [J].
Friso de Beer ;
Wim Lagrand ;
Gerie J. Glas ;
Charlotte J. P. Beurskens ;
Gerard van Mierlo ;
Diana Wouters ;
Sacha Zeerleder ;
Joris J. T. H. Roelofs ;
Nicole P. Juffermans ;
Janneke Horn ;
Marcus J. Schultz .
Cell Biochemistry and Biophysics, 2016, 74 :545-552
[38]   Nebulized C1-Esterase Inhibitor does not Reduce Pulmonary Complement Activation in Rats with Severe Streptococcus Pneumoniae Pneumonia [J].
de Beer, Friso ;
Lagrand, Wim ;
Glas, Gerie J. ;
Beurskens, Charlotte J. P. ;
van Mierlo, Gerard ;
Wouters, Diana ;
Zeerleder, Sacha ;
Roelofs, Joris J. T. H. ;
Juffermans, Nicole P. ;
Horn, Janneke ;
Schultz, Marcus J. .
CELL BIOCHEMISTRY AND BIOPHYSICS, 2016, 74 (04) :545-552
[39]   C1 inhibitor-mediated myocardial protection from chronic intermittent hypoxia-induced injury [J].
Fu, Jinrong ;
Guo, Furong ;
Chen, Cheng ;
Yu, Xiaoman ;
Hu, Ke ;
Li, Mingjiang .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (04) :2208-2214
[40]   Effects of Ischemic Preconditioning and C1 Esterase Inhibitor Administration following Ischemia-Reperfusion Injury in a Rat Skin Flap Model [J].
Masa, Inmaculada ;
Casado-Sanchez, Cesar ;
Crespo-Lora, Vicente ;
Ballestin, Alberto .
JOURNAL OF RECONSTRUCTIVE MICROSURGERY, 2021, 37 (03) :242-248